US-based venture firms Dow Capital Venture and Sail Venture Partners are leading the more than $10 million series D financing of cleantech company WaterHealth International.
WaterHealth has more than 600 installations of its water purification and disinfection systems in developing countries around the world. It also invests in health and hygiene education programs and has offices in the US, India, the Philippines and Ghana.
The funding will help WaterHealth scale up its operations and expand the number of communities it serves, said Tralance Addy, chairman and chief executive of the company.
In December 2006, Sail Venture Partners made a $4 million investment in WaterHealth’s series C funding. This followed Dow Venture Capital’s $7.25 million investment in the same funding round in November 2006.
Dow Venture Capital is the venture arm of The Dow Chemical Company, a diversified chemical company. It is interested in the communications and IT; life sciences and biotechnology; and physical science sectors in North America, Europe and Asia.
Sail Venture Partners invests through two primary funds, which focus on clean technologies in the alternative energy, water, agriculture and materials sectors.